Advertisement
Advertisement

SCLX

SCLX logo

Scilex Holding Company Common Stock

8.57
USD
Sponsored
-0.12
-1.36%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

8.63

+0.06
+0.73%

SCLX Earnings Reports

Positive Surprise Ratio

SCLX beat 2 of 8 last estimates.

25%

Next Report

Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
$12.34M
/
-$0.96
Implied change from Q3 25 (Revenue/ EPS)
+16.87%
/
--
Implied change from Q4 24 (Revenue/ EPS)
-17.17%
/
--

Scilex Holding Company Common Stock earnings per share and revenue

On Nov 14, 2025, SCLX reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.83 USD, resulting in a --% surprise. Revenue reached 10.56 million, compared to an expected 26.77 million, with a -60.56% difference. The market reacted with a -12.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.96 USD, with revenue projected to reach 12.34 million USD, implying an -- of --% EPS, and increase of 16.87% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Scilex Holding Company Common Stock reported EPS of --, missing estimates by --, and revenue of $10.56M, -60.56% below expectations.
The stock price moved down -12.32%, changed from $17.69 before the earnings release to $15.51 the day after.
The next earning report is scheduled for Mar 30, 2026.
Based on 3 analysts, Scilex Holding Company Common Stock is expected to report EPS of -$0.96 and revenue of $12.34M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement